Delivery Order SPE2DB22D2108-SPE2DB25FU4VY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,218.65 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, effective May 20, 2025, with completion targeted for May 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a $8,658.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pharmaceutical product, with an ultimate completion date of June 17, 2025. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $19,734.44 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 28, 2025. This competitive award (no set-aside designation) represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The product...
- The Defense Logistics Agency awarded a $25,312.37 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of June 26, 2025. This non-set-aside, competitively awarded contract operates under firm fixed pricing and represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $62,369.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a $41,759.43 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,482.80 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pharmaceutical product. The award, issued on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract...
- The Defense Logistics Agency awarded a $1,513.48 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product for cholesterol management. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,336.55 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 15, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed under AmerisourceBergen's broader relationship with DLA for pharmaceutical supply. The product is a PCSK9 inhibitor used for cholesterol management, reflecting the company's ongoing role in supplying...
- The Defense Logistics Agency awarded a delivery order valued at $8,232.28 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 13, 2025. This competitive, firm fixed-price delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's existing contract vehicle with DLA. The award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU4VYDelivery Order
The Defense Logistics Agency awarded a $8,009.60 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of June 24, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product being supplied is a cardiovascular/lipid management pharmaceutical used to reduce low-density lipoprotein cholesterol levels, supporting military healthcare needs across the federal medical supply chain. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds a substantial $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX) that extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. The Defense Logistics Agency is currently planning Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards across separate regions, positioning AmerisourceBergen to continue serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 6/23/25 |